Novel assays to investigate the mechanisms of latent infection with HIV-2.
Although there have been great advancements in the field of HIV treatment and prevention, there is no cure. There are two types of HIV: HIV-1 and HIV-2. In addition to genetic differences between the two types of HIV, HIV-2 infection causes a slower disease progression, and the rate of new HIV-2 inf...
Main Authors: | Michael D Lu, Sushama Telwatte, Nitasha Kumar, Fernanda Ferreira, Holly Anne Martin, Gayatri Nikhila Kadiyala, Adam Wedrychowski, Sara Moron-Lopez, Tsui-Hua Chen, Erin A Goecker, Robert W Coombs, Chuanyi M Lu, Joseph K Wong, Athe Tsibris, Steven A Yukl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0267402 |
Similar Items
-
Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency
by: Sushama Telwatte, et al.
Published: (2019-11-01) -
Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
by: Suhui Zhao, et al.
Published: (2021-06-01) -
Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals.
by: Sara Moron-Lopez, et al.
Published: (2020-11-01) -
Single cell analysis reveals molecular signatures of HIV latency in primary cell models
by: S. Telwatte, et al.
Published: (2019-12-01) -
Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency.
by: Sushama Telwatte, et al.
Published: (2018-11-01)